Clinical trials: WHIM

Healthy

G-CSF and AMD3100 to Mobilize Stem Cells in Healthy Volunteers

• Completed
• Age: 18 to 60 years
• Phase 2
• Results posted

This 12-day study will test whether the combination of G-CSF (granulocyte-colony stimulating factor) and AMD3100 (Mozobil) is more efficient in mobilizing stem cells for collection than the use of G-CSF alone.

Trial name

NCT00082329

Testing

AMD 3100 (Mozobil plerixafor), Granulocyte colony-stimulating factor (G-CSF)

Where

United States

Volunteers

9 people, healthy volunteers welcome

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)